Published in J Cell Commun Signal on April 21, 2015
How do benign myoepithelial cells from in situ areas of carcinoma ex-pleomorphic adenoma favor tumor progression? J Cell Commun Signal (2015) 0.75
Diversity of Cnidarian Muscles: Function, Anatomy, Development and Regeneration. Front Cell Dev Biol (2017) 0.75
Effect of epithelial growth factor on matrix metalloproteinase-2 and E-cadherin/β-catenin expression in an in situ model of tumorigenesis. Oncol Lett (2017) 0.75
Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55
The role of autophagy in cancer development and response to therapy. Nat Rev Cancer (2005) 8.18
Cell biology: autophagy and cancer. Nature (2007) 4.40
Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res (2007) 3.49
Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res (2011) 3.18
Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif (2012) 3.18
Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie (2007) 2.95
Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene (2004) 2.81
What has senescence got to do with cancer? Cancer Cell (2005) 2.55
Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev (2010) 2.49
The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res (1997) 2.08
Role and regulation of autophagy in cancer. Biochim Biophys Acta (2009) 2.00
Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol (2011) 1.98
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Cell Death Dis (2010) 1.87
Cellular senescence: hot or what? Curr Opin Genet Dev (2009) 1.68
Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle (2012) 1.63
The myoepithelial defense: a host defense against cancer. Med Hypotheses (1997) 1.53
Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia (2005) 1.50
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol (2011) 1.43
CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle (2012) 1.37
Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology (2005) 1.31
CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle (2012) 1.29
Apoptosis: why and how does it occur in biology? Cell Biochem Funct (2011) 1.29
Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol (2013) 1.28
Autophagy and tumorigenesis. Semin Immunopathol (2010) 1.26
Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) (2011) 1.22
Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol (2009) 1.22
Premature senescence of endothelial cells: Methusaleh's dilemma. Am J Physiol Heart Circ Physiol (2006) 1.22
The role of apoptosis in tumor progression and metastasis. Curr Mol Med (2003) 1.20
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol (2012) 1.16
Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol (2003) 1.16
The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res (1998) 1.15
Autophagy facilitates oncogene-induced senescence. Autophagy (2009) 1.13
Investigations of survivin: the past, present and future. Front Biosci (Landmark Ed) (2011) 1.10
Immunoprofile of reactive salivary myoepithelial cells in intraductal areas of carcinoma ex-pleomorphic adenoma. Oral Oncol (2006) 1.08
The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene (2000) 1.07
Senescence regulation by mTOR. Methods Mol Biol (2013) 0.92
FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study. J Appl Oral Sci (2010) 0.90
A proposal of an in vitro model which mimics in situ areas of carcinoma. J Cell Commun Signal (2012) 0.86
FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures. Oncol Rep (2010) 0.86
Radiotherapy response in oral squamous carcinoma cell lines: evaluation of apoptotic proteins as prognostic factors. Head Neck (2007) 0.84
In vitro cytokine expression in in situ-like areas of malignant neoplasia. Arch Oral Biol (2012) 0.84
Ductal carcinoma in situ of the breast: can biomarkers improve current management? Clin Chem (2013) 0.81
Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma. Hum Pathol (2012) 0.80
In vitro evaluation of the suppressor potential of conditioned medium from benign myoepithelial cells from pleomorphic adenoma in malignant cell invasion. J Oral Pathol Med (2012) 0.78
How do benign myoepithelial cells from in situ areas of carcinoma ex-pleomorphic adenoma favor tumor progression? J Cell Commun Signal (2015) 0.75